WASHINGTON – The US Department of Justice points the finger at the pharmaceutical industry for generic medicines. And announces the first formal charges against two managers, 
The allegations come at the end of two years of investigations involving more than a dozen companies and about twenty drugs. The accused are Jeffrey Glazer, the former CEO of Heritage Pharmaceuticals, and Jason Malek, the company's former president.
Article by Ats/DO – 14/12/2016 – tio.ch.news
